Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Link
https://link.springer.com/content/pdf/10.1007/s10620-021-07117-9.pdf
Reference36 articles.
1. Jeuring SF, van den Heuvel TR, Zeegers MP et al. Epidemiology and long-term outcome of inflammatory bowel disease diagnosed at elderly age-an increasing distinct entity? Inflamm Bowel Dis. 2016;22:1425–1434.
2. Everhov AH, Halfvarson J, Myrelid P et al. Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden. Gastroenterology 2018;154:518-528 e15.
3. Benchimol EI, Manuel DG, Guttmann A et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis. 2014;20:1761–1769.
4. LeBlanc JF, Wiseman D, Lakatos PL et al. Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape. World J Gastroenterol 2019;25:4158–4171.
5. Charpentier C, Salleron J, Savoye G et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 2014;63:423–432.
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Use of real-world data to assess the effectiveness of ustekinumab in treating IBD patients: a retrospective linked database study in northwest London;Expert Opinion on Biological Therapy;2023-11-27
2. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—IBD in Seniors;Journal of the Canadian Association of Gastroenterology;2023-09-01
3. Management of inflammatory bowel disease in the elderly: A review;Digestive and Liver Disease;2023-08
4. Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s disease;Indian Journal of Gastroenterology;2023-07-31
5. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry;Journal of Crohn's and Colitis;2023-07-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3